This is the first of a 2-part round-table discussion that brings together the expertise of a dermatologist, medical oncologist, and Mohs surgeon and pairs it with a first-hand account of how Jim, a cutaneous squamous cell carcinoma (cSCC) survivor, and his caregiver navigated the ups and downs of a rapidly-metastatic cSCC diagnosis and treatment labyrinth. In this activity, learners will explore pressing questions regarding the safety and efficacy of new systemic options for managing advanced cSCC not otherwise amenable to curative surgical strategies.
Upon completion of this activity, participants should be better able to:
Associate Professor, Dermatology
Harvard Medical School
Director, Mohs and Dermatologic Surgery Center
Dana-Farber/Brigham and Women’s Cancer Center
Boston, MA
Chief, Translational Research and Immunotherapy
Director, Cutaneous Oncology
The Angeles Clinic and Research Institute
Los Angeles, CA
Assistant Professor, Division of Dermatology
Department of Internal Medicine
The University of Texas
Austin Dell Medical School
Austin, TX
Featured RMEI CE Activities – Earn CE Credit(s)
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
